• 한국융합학회논문지
• /
• 제8권12호
• /
• pp.391-395
• /
• 2017

본 연구에서는 안경 조제 가공료와 피팅비 필요성 및 정착화에 필요한 내용에 대한 설문조사를 실시하였다. 2016년 8월 1일부터 9월 30일까지 서울, 경기 지역의 안경사 202명을 대상으로 각 설문항목을 설정하고 온라인 오프라인으로 설문조사를 실시하였다. 모든 자료의 통계처리는 Origin Pro 8.5를 사용하여 실시하였다. 안경 조제 가공료와 피팅비 도입의 필요성에 대하여서는 각각 92.1%(186명), 93.1%(188명)가 도입 필요성에 대해서 긍정적으로 평가하고 있었다. 안경 조제 가공료와 피팅비에 대한 설문분석 및 해외사례를 통해 안정화된 정책을 제공함으로써 보건의료 서비스 전문가로서 안경사의 위치를 정립하여야 할 필요가 있다고 조사되었다.

• 한국임상약학회지
• /
• 제34권1호
• /
• pp.30-38
• /
• 2024

Background: This study examined the public's perceptions of repeat dispensing as one of the measures to reduce the harmful effects of long-term prescriptions in Korea. Methods: From January 11 to 25, 2021, an online survey was conducted for adults using convenience sampling. A self-developed questionnaire was used. Results: There were 310 respondents, of which 228 (73.5%) preferred repeat dispensing. When considering the additional fee payment, 188 (60.6%) preferred repeat dispensing, and 54 (67.5%) out of a total of 80 chronic disease patients preferred it. It was confirmed that there was a difference in the willingness to repeat dispensing considering the additional cost depending on whether the patient had a chronic disease and the distance from home to the nearest pharmacy. As a result of subgroup analysis for patients with chronic diseases, frequency of outpatient visit, number of prescription days, method of packaging pharmaceuticals, and distance from home to the nearest pharmacy were identified as variables that could well predict the willingness to repeat dispensing considering paying additional fees. The preference for repeat dispensing may vary depending on conditions such as additional cost range, frequency and period of prescription use, disease and patient characteristics, so a careful approach is necessary. Conclusion: It is necessary for the government to consider the introduction of repeat dispensing with interest in the public demand.

• 약학회지
• /
• 제53권2호
• /
• pp.45-50
• /
• 2009

The purpose of this study is to investigate the best way that health functional food contributes the diversification of pharmacy management at the new point after the separation of prescribing and dispensing practice. In the question of the number of prescription paper, it was more than 200 papers (18.9%), next 100 papers (11.3%). In case of daily total sales volume except prescription fee, it was more than 1,000,000won (28.3%). About the motivation using health functional food, the reason for activation of pharmacy management was 66%. The selling method was mainly by pharmacist recommendation and consumer's need. In comparison with after and before the separation of prescribing and dispensing, more than 60% of subjects answered that sales volume was decreased and no changed. Concerning the ratio of total sales volume to health functional food within 5 years, 66% of subjects expected that it will be increased positively. The type of best pharmacy to handle health functional food was community pharmacy. These results suggest that the handling of health functional food by pharmacist will greatly increase in near futures and will be very important portion for pharmacy management.

• 의료법학
• /
• 제15권1호
• /
• pp.123-164
• /
• 2014

Under the new system of 'Separation of pharmaceutical prescription and dispensing' in Korea, which was implemented in 2000, physician could not dispense a medicine, and outpatient should have a physician's prescription filled at a drugstore. After pharmacist makes up outpatient's prescription, National Health Insurance Service(NHIS) pay for outpatient's medicine to pharmacist, except an outpatient's own medicine charge. And NHIS only pay for outpatient's prescription fee to physician and, physician doesn't derive profit from dispensing medicine in itself. Nevertheless, if physician writes out a prescription with violation of 'Criteria for the Medical Care Benefits', NHIS clawed back the payment of outpatient's prescription and medicine from the physician or the medical institution which the physician belongs to. In the past, NHIS's confiscation was in accordance with 'the National Health Care Insurance Act, Article 52, Clause 1'. But, since 2006 when the Supreme Court declared that there was no legal basis on the NHIS's confiscation of outpatient's medicine payment, NHIS had put in a claim for illegal prescriptions on the basis 'the Korean Civil law, Article 750(tort)'. So, Many medical institutions filed civil actions against NHIS. The key point of this actions was whether the issuing outpatient prescriptions with violations of Criteria for the Medical Care Benefits constitute of the law of tort. On this point, the first trial and the second trial took different position. Finally the Supreme Court acknowledged the constitution of the law of tort in 2013. In this paper, the author will review critically the decision of the Supreme Court, and consider the relativeness between the legal effect of Criteria for the Medical Care Benefits and the constitution of the issuing outpatient prescriptions with violations of Criteria for the Medical Care Benefits as the law of tort.

• 보건행정학회지
• /
• 제12권4호
• /
• pp.91-113
• /
• 2002

본 논문은 의약분업의 실시와 이에 따른 의료인의 대규모 파업을 연구 대상으로 하였다. 협상 (bargaining)에 관한 게임이론 (game-theory) 모형을 활용하여 의료인들과 정부의 협상과 정과 결과를 분석하고자 하였다. 특히 제도 변화의 과정에 있어 사회적 행위자들 사이의 분배적 갈등의 역할에 초점을 맞추고 있다 정부에 의한 의약분업의 시행은 의료인들로 하여금 심각한 분배적 결과를 초래할 수 있다는 것이며, 이는 다양한 배경의 의료인들로 하여금 정치적 연합의 가능성을 강화시켰다. 의료인들에 의한 분배적 결과의 인식은 파업과 같은 집합행동의 조직화로 나타나고 정부와의 협상 관계에 있어서도 줄곧 협상력의 우위를 견지하는 모습을 보여주었다. 결과적으로 의료인들은 그들이 원하는 결과를 확보하는데 성공한듯이 보인다. 협상은 제도의 형성과 변화에 있어 행위자들 간 상호작용의 중요한 형태라 할 수 있다. 이 경우 한 행위자의 목적은 그들에 유리하게 어떻게 제도적 규칙을 형성해 나가느냐 이다. 행위자들간 이해관계에 따른 갈등의 분석에 있어 주요한 변수는 당사자들 간 협상력의 차이라 할 수 있다. 힘의 비대칭 (asymmetry of power)현상은 제도 형성의 중요한 요소가 될 수 있다. 본 논문은 비협조 게임 모형 (the battle of sexes game)을 이용하여 협상력의 차이에 따른 균형해(equilibrium outcome)의 차이를 분석하고자 하였다. 특히 정부와 의료인의 협상에 있어 선호의 강도(intensity of preference)와 협상의 결렬시 지불해야 하는 비용 (breakdown cost) 의 차이는 협상력의 차이로 이어지고, 결과적으로 제도 변화의 결과를 가늠케 하는 척도로 작용하고 있음을 알 수 있다.

• 한국병원경영학회지
• /
• 제7권4호
• /
• pp.1-23
• /
• 2002

This study examined the influence of the separation of prescribing and dispensing roles(SPD) policy implemented in Korea in July 2000, especially on the change in the net profit of medical institutions. Using the data set from the Korea's National Health Insurance and the previous research, this study elicited the following main results. First, tertiary care institutions was estimated to lose about 631 billion won after the SPD policy. Second, general hospitals and hospitals gained about 557 billion and 564 billion won, respectively. Third, it is shown that clinics also gained 389-659 billion won. Finally, however, the change in net profit of medical institutions after the SPD policy largely depends on different estimation models. Moreover, it also varies from the assumptions on the price differential of a reimbursable drug which worked as cross-subsidy to insufficient physician's fee before the SPD policy. Despite such limitations as lack of data outside of the National Health Insurance's coverage, this study differs from others. This is the first research to explore the effect of the SPD policy on different types of medical institutions and to attempt to purely focus on the SPD policy. In this study, we can draw the policy implication that preparing for a policy change, the government should set up the policy evaluation system to collect the concerned data and develop the methodologies in advance to the policy implementation.

• 한국콘텐츠학회논문지
• /
• 제22권6호
• /
• pp.712-728
• /
• 2022

세계적으로 노인인구 급증으로 병용약물이 늘어나고, 의료기술의 발달에 따라 다양한 질병 상태의 해소를 위한 약물사용이 늘어나고 있어, 약물의 효과적이고 안전한 사용을 위해 약사의 전문지식에 대한 기대 및 요구는 점차 높아지고 있다. 이에 우리나라는 지난 2009년부터 기존 4년 교육이 아닌 6년제로 약학대학의 학제를 개편하였으며, 고도화된 약료서비스의 제공을 위해 준비된 전문인력을 배출하고 있다. 그러나 현행 국민건강보험 급여체계는 여전히 전통적 약사의 역할인 조제를 중심으로 산정되어, 약사가 제공하거나 제공 가능한 서비스와, 실제로 지급되는 보상급여 간 극심한 간극이 존재하고 있다. 이에 본 연구에서는 약료서비스 지불보상제도의 국제적 동향을 비교분석하여, 현행 한국의 지불보상체계에 시사점을 주고자 하였다. 한국과 일본, 영국 및 미국의 약사서비스 지불보상정책 및 관련 문헌을 검토한 결과, 일본, 영국 및 미국의 시스템은 환자중심의 약료서비스에 대해 제도적으로 구체적이고 다양한 지불수단을 마련하여 보상하고 있으나, 한국의 약국 서비스는 상대적으로 조제관련 행위만 보상하는 정도에 그치고 있어, 국내 약료서비스의 발전을 구조적으로 저해하는 결과를 낳고 있는 것으로 나타났다. 결론적으로, 안전한 약물사용을 위한 환자중심 약료서비스의 제공을 위해서는 국내 지불보상체계가 인정하는 약료서비스의 범위를 확대하고 관련 서비스의 종류를 다양화하여 국내 약사급여제도를 개선시켜나갈 필요가 있다.

• 대한한의학회지
• /
• 제30권4호
• /
• pp.64-78
• /
• 2009

Objectives: To research Korean oriental medical doctors' use of uninsured herbal extracts and how to bring about the insurance coverage of such herbal extracts. Methods: We surveyed Korean oriental doctors about the following issues from October 17th to November 15th, 2008: (1) Korean oriental medical doctors' knowledge about herbal extract insurance and the circumstances of oriental medicine in Korea, (2) their opinion on the coverage of currently uninsured herbal extracts and the dispensing of herbal extracts from pharmacies rather than from their clinics, (3) their use of herbal extracts, and (4) how to bring about insurance coverage of uninsured herbal extracts. Results: Over 70% of the respondents said that herbal medicine prescriptions have been reduced recently and that the existence of herbal medicine is in danger. In addition, 63.64% respondents agreed with expanding insurance coverage to include currently uninsured herbal extracts in spite of the fact that patients might have to obtain herbal extracts from pharmacies rather than from Korean oriental medical clinics. The average patient number per month of uninsured herbal extracts was 13.64 people, the average dosage was 5.64g, the average cost per day was 3,859 won, and the average prescription period was 2.65 days. Korean oriental medical doctors asked an average of 12,486 won for the medical examination-prescription fee and 3,292 won in fees for prescriptions obtained outside the hospital. If insurance coverage expands to include these herbal extracts, their usage is expected to increase 2.31 times. Conclusions: This study shows Korean oriental medical doctors' use of herbal extracts and their opinions about execution of herbal extracts' insurance. A periodic study such as this one will hopefully aid in establishing polices for uninsured herbal extracts' insurance.